Affiliation:
1. Icahn School of Medicine at Mount Sinai
2. Center for the Prevention and Treatment of Visual Loss
Abstract
Accurate segmentation of retinal layers in optical coherence tomography
(OCT) images is critical for assessing diseases that affect the optic
nerve, but existing automated algorithms often fail when pathology
causes irregular layer topology, such as extreme thinning of the
ganglion cell-inner plexiform layer (GCIPL). Deep LOGISMOS, a hybrid
approach that combines the strengths of deep learning and 3D graph
search to overcome their limitations, was developed to improve the
accuracy, robustness and generalizability of retinal layer
segmentation. The method was trained on 124 OCT volumes from both eyes
of 31 non-arteritic anterior ischemic optic neuropathy (NAION)
patients and tested on three cross-sectional datasets with available
reference tracings: Test-NAION (40 volumes from both eyes of 20 NAION
subjects), Test-G (29 volumes from 29 glaucoma subjects/eyes), and
Test-JHU (35 volumes from 21 multiple sclerosis and 14 control
subjects/eyes) and one longitudinal dataset without reference
tracings: Test-G-L (155 volumes from 15 glaucoma patients/eyes). In
the three test datasets with reference tracings (Test-NAION, Test-G,
and Test-JHU), Deep LOGISMOS achieved very high Dice similarity
coefficients (%) on GCIPL: 89.97±3.59,
90.63±2.56, and 94.06±1.76, respectively. In the same
context, Deep LOGISMOS outperformed the Iowa reference algorithms by
improving the Dice score by 17.5, 5.4, and 7.5, and also surpassed the
deep learning framework nnU-Net with improvements of 4.4, 3.7, and
1.0. For the 15 severe glaucoma eyes with marked GCIPL thinning
(Test-G-L), it demonstrated reliable regional GCIPL thickness
measurement over five years. The proposed Deep LOGISMOS approach has
potential to enhance precise quantification of retinal structures,
aiding diagnosis and treatment management of optic nerve diseases.
Funder
Rehabilitation Research and Development
Service
National Institute of Biomedical Imaging
and Bioengineering
National Eye Institute